LENSAR, Inc. Files 8-K for Q1 2026 Financials
Ticker: LNSR · Form: 8-K · Filed: Mar 31, 2026 · CIK: 0001320350
| Field | Detail |
|---|---|
| Company | Lensar, Inc. (LNSR) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2026 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, results-of-operations
TL;DR
LENSAR dropped its Q1 2026 8-K. Check financials.
AI Summary
LENSAR, Inc. filed an 8-K on March 31, 2026, reporting its financial results and condition for the period ending March 31, 2026. The filing includes financial statements and exhibits, with the primary document being the 8-K itself in iXBRL format.
Why It Matters
This filing provides investors with crucial financial updates for LENSAR, Inc., detailing their performance and financial standing as of the first quarter of 2026.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing and does not indicate any unusual risks.
Key Players & Entities
- LENSAR, Inc. (company) — Filer of the 8-K report
- 0001320350 (company) — CIK number for LENSAR, Inc.
- 2026-03-31 (date) — Period of report and filing date
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report LENSAR, Inc.'s Results of Operations and Financial Condition for the period ending March 31, 2026, and to include Financial Statements and Exhibits.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on March 31, 2026, at 06:10:09.
What is LENSAR, Inc.'s business address?
LENSAR, Inc.'s business address is 2800 DISCOVERY DRIVE SUITE 100 ORLANDO FL 32826.
What SIC code is associated with LENSAR, Inc.?
The SIC code associated with LENSAR, Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
What document types are included in this filing?
This filing includes an 8-K in iXBRL format, an exhibit (EX-99.1), a graphic file, a complete submission text file, an XBRL taxonomy extension schema, and an extracted XBRL instance document.
Filing Stats: 521 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2026-03-31 06:10:09
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share LNSR The Nasdaq Stock Mar
Filing Documents
- lnsr-20260331.htm (8-K) — 44KB
- lnsr-ex99_1.htm (EX-99.1) — 490KB
- img39955300_0.gif (GRAPHIC) — 20KB
- 0001193125-26-133153.txt ( ) — 689KB
- lnsr-20260331.xsd (EX-101.SCH) — 24KB
- lnsr-20260331_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On March 31, 2026, LENSAR, Inc. (the "Company") issued a press release announcing financial results for the fiscal quarter and year ended December 31, 2025. A copy of the Company's press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of LENSAR, Inc., dated March 31, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LENSAR, Inc. Date: March 31, 2026 By: /s/ Nicholas T. Curtis Name: Title: Nicholas T. Curtis Chief Executive Officer